These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26994213)

  • 1. Study duration for three-arm non-inferiority survival trials designed for accrual by cohorts.
    Wu Y; Li Y; Hou Y; Li K; Zhou X
    Stat Methods Med Res; 2018 Feb; 27(2):507-520. PubMed ID: 26994213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.
    Kombrink K; Munk A; Friede T
    Stat Med; 2013 Aug; 32(18):3055-66. PubMed ID: 23508697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correcting for non-compliance in randomized non-inferiority trials with active and placebo control using structural models.
    Wu Y; Zhao L; Hou Y; Li K; Zhou X
    Stat Med; 2015 Mar; 34(6):950-65. PubMed ID: 25534903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
    Mielke M; Munk A; Schacht A
    Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
    Tang NS; Yu B; Tang ML
    BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
    Hida E; Tango T
    Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials.
    Koopmeiners JS; Hobbs BP
    Stat Methods Med Res; 2018 May; 27(5):1547-1558. PubMed ID: 27587591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and analysis of three-arm trials with negative binomially distributed endpoints.
    Mütze T; Munk A; Friede T
    Stat Med; 2016 Feb; 35(4):505-21. PubMed ID: 26388314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
    Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
    Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A studentized permutation test for three-arm trials in the 'gold standard' design.
    Mütze T; Konietschke F; Munk A; Friede T
    Stat Med; 2017 Mar; 36(6):883-898. PubMed ID: 27859506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A computer program for sample size and power calculations in the design of multi-arm and factorial clinical trials with survival time endpoints.
    Natarajan R; Turnbull BW; Slate EH; Clark LC
    Comput Methods Programs Biomed; 1996 Mar; 49(2):137-47. PubMed ID: 8735021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A more efficient three-arm non-inferiority test based on pooled estimators of the homogeneous variance.
    Lu H; Jin H; Zeng W
    Stat Methods Med Res; 2018 Aug; 27(8):2437-2446. PubMed ID: 27920362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planning and analysis of three-arm non-inferiority trials with binary endpoints.
    Kieser M; Friede T
    Stat Med; 2007 Jan; 26(2):253-73. PubMed ID: 16685703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
    Wang YC; Chen G; Chi GY
    J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of multiple testing procedures for the gold standard non-inferiority trial.
    Röhmel J; Pigeot I
    J Biopharm Stat; 2010 Sep; 20(5):911-26. PubMed ID: 20721781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some practical considerations in three-arm non-inferiority trial design.
    Zhou M; Kundu S
    Pharm Stat; 2016 Nov; 15(6):550-559. PubMed ID: 27681603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.